IPO Boutique

Ariosa Diagnostics Inc., IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Ariosa Diagnostics Inc.,, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Ariosa Diagnostics Inc.,AROS -
NASDAQ
TBD $0.00 $0.00TBD
J.P. Morgan, Citigroup
Co-Manager(s):
Leerink Partners, William Blair
Filing(s):

Filed 2014-03-25
Terms Added 2014-04-25
Re-Filed 2014-04-29



About Ariosa Diagnostics Inc., (adapted from Ariosa Diagnostics Inc., prospectus):
They are a global commercial-stage molecular diagnostics company focused on improving overall patient care by developing and delivering innovative, affordable and widely-accessible genetic testing.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "AROS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved